Market cap
$216 Mln
Market cap
$216 Mln
Revenue (TTM)
$363 Mln
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
12.1
Debt to Equity
0.2
Book Value
$--
EPS
$-0.8
Face value
--
Shares outstanding
59,126,604
CFO
CA$-1,068.84 Mln
EBITDA
CA$-1,204.65 Mln
Net Profit
CA$-6,234.43 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aurora Cannabis (ACB)
| -12.9 | 12.7 | -13.3 | -12.5 | -15.9 | -46.2 | -23.1 |
|
BSE Sensex
| -7.3 | 5.3 | -4.1 | -1.1 | 9.6 | 10.5 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Aurora Cannabis (ACB)
| -0.7 | -48.4 | -82.9 | -34.9 | -67.9 | -56.5 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aurora Cannabis (ACB)
|
3.7 | 216.4 | 363.3 | -42.5 | 0.1 | -6 | -- | 0.6 |
| 1.6 | 168.6 | 0.0 | -33.8 | -- | -158.8 | -- | 13.0 | |
| 0.4 | 2.4 | 54.7 | -11.3 | -16.3 | -516.3 | -- | 0.9 | |
| 1.5 | 391.4 | 946.4 | -15.8 | -1.2 | -1.4 | -- | 0.5 |
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant... Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada. Read more
CEO & Director
Mr. Miguel Martin
CEO & Director
Mr. Miguel Martin
Headquarters
Edmonton, AB
Website
The share price of Aurora Cannabis Inc (ACB) is $3.68 (NASDAQ) as of 22-Apr-2026 11:36 EDT. Aurora Cannabis Inc (ACB) has given a return of -15.88% in the last 3 years.
Since, TTM earnings of Aurora Cannabis Inc (ACB) is negative, P/E ratio is not available.
The P/B ratio of Aurora Cannabis Inc (ACB) is 0.56 times as on 17-Apr-2026, a 95 discount to its peers’ median range of 12.14 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
151.76
|
0.43
|
|
2024
|
-2.72
|
0.34
|
|
2023
|
-0.07
|
0.04
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
The 52-week high and low of Aurora Cannabis Inc (ACB) are Rs 6.67 and Rs 3.07 as of 22-Apr-2026.
Aurora Cannabis Inc (ACB) has a market capitalisation of $ 216 Mln as on 17-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Aurora Cannabis Inc (ACB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.